Greeley Tribune, Greeley Tribune News, Greeley Tribune Sports

Why is Modern still refusing to share a version of the COVID-19 vaccine?

Modernism is already on fire globally to prioritize the vaccine demands of rich countries in the ongoing fight against COVID 19, the chairman and co-founder reiterated on Monday that the US company will not share its vaccine formula.

In one Interview with Associated PressModerina’s Nobar Affian claims that appeals from the World Health Organization (WHO) and others for prescription sharing assumed that “we haven’t had enough capacity, but in fact we know we can.” Are. ”

“Within the next six to nine months, the most reliable and effective way to make high-quality vaccines is if we make them,” Afyan said. Food in less time “and” we think we can go from one to three billion next year. ”

“We think we are doing everything we can to help this epidemic.” Named To ForbesLast week, for the first time, a list of the 400 richest people in the United States.

Afyan also said Moderna – who has. Received The multibillion-dollar development by the U.S. government and its messenger RNA (mRNA) vaccine dose will not enforce patent infringement during epidemic diseases, he added, adding, “We didn’t have to.” ۔ ”

“We think it was the right thing to do,” he said. “We want it to help the world.”

Critics of Modrina and other vaccine makers have argued that Big Pharma could help fight the epidemic by supporting it. Patent waiver And extensive sharing of information about vaccines and treatments needed to increase productivity rapidly.

Last week, Moderina announced that it would “build a state-of-the-art MRNA facility in Africa that aims to produce up to 500 million doses of vaccine each year.”

As Normal dream ReportedCritics warn that the move could be nothing more than a “PR trick” to “divert attention” from the patent waiver for the Kovid 19 vaccine and the WHO’s MRNA technology transfer initiative in South Africa. Designed to block or derail conversations altogether.

Modern also came under fire later. New York Times Reported On Saturday, the company said it was “delivering its shots almost exclusively to rich countries, awaiting poor countries and making billions in profits.”

Noting that “according to AirFenty, a data firm that tracks vaccine shipments, Modern has shipped more of its food to richer countries than any other vaccine maker.”

About one million doses of the modern vaccine have gone to low-income countries in the World Bank. In contrast, 8.4 million Pfizer doses and about 25 million single-shot Johnson & Johnson doses have gone to these countries.

Of the handful of middle-income countries that have made deals to buy Moderina shots, most have not yet received any food, and at least three have had to pay more than the United States or the European Union. A

Unlike Pfizer, Johnson & Johnson, and AstraZeneca, which includes a variety of drugs and other products, Modern does not only sell covid vaccines. The future of the Massachusetts company depends on the commercial success of its vaccine.

In my interview with Afyan AP, Retreating, saying that modernity has provided “significant” production to poor nations and is currently working with a number of governments “to secure supplies for the clear purpose of supplying low-income countries.” I can help them. ”

Dr. Tom Frieden, former head of the U.S. Centers for Disease Control and Prevention, said. Times Modern is “behaving as if there is no obligation on their investment beyond the maximum return.”

%d bloggers like this: